Podcast Episodes
Back to SearchE126: Risk Signals, JAKs, and SELECTIVE-ity
Episode 127
Covering an interesting but ultimately disappointing post hoc study of multiple upadacitinib trials in RA. Initially some hope for clarity in the "Do JAKs cause all the badness?" questions, but ultim…
Published on 1 day, 7 hours ago
E125: Adrenal Insufficiency after Stopping Prednisone
Episode 126
Interesting read this week - I cover a nifty little paper that presented data about adrenal insufficiency after stopping prednisolone, published in JAMA Open in March 2025.
Open Access Journal He…
Published on 2 months, 1 week ago
e124: MTX vs Pred for Pulmonary Sarcoidosis: PREDMETH Study
Episode 125
Interesting NEJM trial this week comparing methotrexate to prednisone for pulmonary sarcoidosis.
Paper available here: https://www.nejm.org/doi/full/10.1056/NEJMoa2501443
Published on 2 months, 4 weeks ago
E123: Upadacitinib for Giant Cell Arteritis: SELECT-GCA
Episode 124
Podcast this week about the recently published SELECT-GCA study, which evaluated the use of the janus kinase inhibitor upadacitinib (Rinvoq) for patients with new and relapsing GCA. Successful trial …
Published on 4 months, 1 week ago
E122: Guidelines for Maybe Diagnosing HLH
Episode 123
This week I cover another of my newsletters, though I mostly use it as a skeleton to riff on a common (and challenging) issue for rheumatology consultants; diagnosing HLH. Check out the guidelines th…
Published on 4 months, 3 weeks ago
E121: Obinutuzumab in SLE-LN
Episode 122
Another day, another b cell podcast. Seems to be all the rage! This week I discuss the recently published NEJM trial of the anti CD20 agent obinutuzumab in lupus nephritis. Worth a read and listen, p…
Published on 5 months, 1 week ago
E120: Real Life Use of PEXIVAS-Low
Episode 121
What do you do when observational data and RCTs conflict? This week I'm covering the "real world PEXIVAS" study that was done by the French Vasculitis Study Group. Great read, interesting issues, hav…
Published on 6 months ago
E119: Teclistamab for Rheumatology Writ Large
Episode 120
One of my rare case-report podcasts, a topic that I typically avoid. The craze about CAR-T has also made me a little crazy, though, so I wanted to share what I think may be the ultimate destination f…
Published on 6 months, 4 weeks ago
E118: The emerging risk of overdiagnosis in RA and PMR
Episode 119
Podcast this week about overdiagnosis! Currently one of my favorite topics and something that I think will be an emerging issue in our field. We recently published a Viewpoint in Lancet Rheumatology …
Published on 7 months, 1 week ago
E117: Inebilizumab for IgG4-RD (MITIGATE)
Episode 118
New RCT in a new disease with a new drug! But is it as shiny as one would hope? Interesting discussion today about what a trial means, how it will affect practice, and how we could do better as a fie…
Published on 9 months ago